封面
市場調查報告書
商品編碼
1370366

生物晶片市場:2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Biochips Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

概要

市場概況:

2022年全球生物晶片市場規模達169億美元。展望未來,IMARC Group預計到2028年市場規模將達到406億美元,2023-2028年年複合成長率(CAGR)為15.8%。慢性病的盛行率不斷上升、對個人化藥物的偏好不斷增加以及對早期檢測癌細胞的需求不斷增加是推動市場發展的一些關鍵因素。

生物晶片是指一種微型醫療設備,旨在在更短的時間內同時執行多個生化反應。它們包含排列在固體基質表面上的一組微測試位點或微陣列。它們以脫氧核糖核酸 (DNA)、蛋白質、酵素和晶片實驗室的形式被廣泛使用。它們結構緊湊、功能強大、快速、易於使用,並且能夠準確地提供關鍵見解。它們非常適合儲存個人醫療和財務訊息,並且可以輕鬆追蹤人類或動物。它們被植入體內,協助監測、分析和控制患者的健康狀況和體內的生物過程。除此之外,它們還有助於識別潛在危險、確保安全的環境和改善決策。因此,生物晶片在全球個體中的基因、腫瘤學、發炎診斷和分子分析中得到了應用。

生物晶片市場趨勢:

目前,糖尿病、血壓和慢性阻塞性肺病(COPD)等慢性病盛行率不斷上升,是支持全球市場成長的關鍵因素之一。除此之外,生物晶片在基因組學、蛋白質組學和分子診斷領域的日益普及正在對市場產生積極影響。此外,生物晶片提供的各種好處,例如減少時間和金錢以及無需重型儀器即可提供高通量的能力,正在促進市場的成長。除此之外,全球醫療保健產業對省時且高品質設備的需求不斷增加。再加上人們越來越偏好個人化藥物和下一代定序(NGS)來治療個體中的多種疾病,正在推動市場的成長。除此之外,擴大採用生物晶片來早期檢測體內癌細胞,這為產業投資者提供了利潤豐厚的成長機會。此外,老年人口的不斷增加,以及世界各地對用於藥物開發和發現的生物晶片的需求不斷成長,正在提供良好的市場前景。此外,基於微流體的設備的生物醫學進步和晶片實驗室的創新在傳染病的初步診斷中提供快速結果正在推動市場的成長。

本報告回答的關鍵問題:

  • 迄今為止,全球生物晶片市場表現如何,未來幾年將如何表現?
  • 全球生物晶片市場的促進因素、限制因素和機會是什麼?
  • 每個促進因素、限制因素和機會對全球生物晶片市場有何影響?
  • 主要區域市場有哪些?
  • 哪些國家代表了最具吸引力的生物晶片市場?
  • 依產品類型分類的市場是怎麼樣的?
  • 生物晶片市場上最具吸引力的產品類型是什麼?
  • 基於製造技術的市場區隔是什麼?
  • 生物晶片市場上最具吸引力的製造技術是什麼?
  • 根據分析方法,市場的細分是什麼?
  • 生物晶片市場上最具吸引力的分析方法是什麼?
  • 基於應用程式的市場區隔是什麼?
  • 生物晶片市場最有吸引力的應用是什麼?
  • 基於最終用戶的市場區隔是什麼?
  • 生物晶片市場上最有吸引力的最終用戶是誰?
  • 全球生物晶片市場的競爭格局如何?
  • 誰是全球生物晶片市場的主要參與者/公司?

目錄

第 1 章:前言

第 2 章:範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章:執行摘要

第 4 章:簡介

  • 概述
  • 主要行業趨勢

第 5 章:全球生物晶片市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章:依產品類型分類的市場區隔

  • DNA晶片
    • 市場走向
    • 市場預測
  • 蛋白質晶片
    • 市場走向
    • 市場預測
  • 晶片實驗室
    • 市場走向
    • 市場預測
  • 酵素晶片
    • 市場走向
    • 市場預測

第 7 章:依製造技術分類的市場

  • 微陣列
    • 市場走向
    • 市場預測
  • 微流控
    • 市場走向
    • 市場預測

第 8 章:按分析方法進行市場區隔

  • 電泳
    • 市場走向
    • 市場預測
  • 發光
    • 市場走向
    • 市場預測
  • 質譜
    • 市場走向
    • 市場預測
  • 電訊號
    • 市場走向
    • 市場預測
  • 磁性
    • 市場走向
    • 市場預測

第 9 章:按應用分類的市場區隔

  • 分子分析
    • 雜交
      • 市場走向
      • 市場預測
    • 蛋白質
      • 市場走向
      • 市場預測
    • 免疫學
      • 市場走向
      • 市場預測
    • 生物分子
      • 市場走向
      • 市場預測
    • 生物標記
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 診斷
    • 基因診斷
      • 市場走向
      • 市場預測
    • 腫瘤學
      • 市場走向
      • 市場預測
    • 發炎
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 非生物用途
    • 市場走向
    • 市場預測

第 10 章:最終用戶的市場區隔

  • 製藥和生物技術公司
    • 市場走向
    • 市場預測
  • 醫院和診斷中心
    • 市場走向
    • 市場預測
  • 學術及研究機構
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 11 章:按地區分類的市場細分

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 亞太地區
    • 中國
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 墨西哥
      • 市場走向
      • 市場預測
    • 巴西
      • 市場走向
      • 市場預測
    • 阿根廷
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 土耳其
      • 市場走向
      • 市場預測
    • 沙烏地阿拉伯
      • 市場走向
      • 市場預測
    • 阿拉伯聯合大公國
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測

第 12 章:SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 13 章:價值鏈分析

第 14 章:波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第15章:競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Agilent Technologies, Inc.
    • bioMerieux SA
    • Bio-RAD Laboratories, Inc.
    • CapitalBio Corporation
    • Dynamic Biosensors GmbH
    • EMD Millipore Corporation
    • Fluidigm Corporation
    • Illumina, Inc.
    • Perkinelmer, Inc.
    • Thermo Fisher Scientific, Inc.
Product Code: SR112023A2741

Abstract

Market Overview:

The global biochips market size reached US$ 16.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 40.6 Billion by 2028, exhibiting a growth rate (CAGR) of 15.8% during 2023-2028. The growing prevalence of chronic diseases, increasing preferences for personalized medicines, and rising need for early detection of cancerous cells represent some of the key factors driving the market.

Biochips refer to a miniaturized medical device that is designed to perform several biochemical reactions simultaneously in less time. They comprise a collection of micro-test sites or microarrays, which are arranged on the surface of a solid substrate. They are widely available as deoxyribonucleic acid (DNA), protein, enzyme, and lab-on-a-chip. They are compact, powerful, fast, easy to use, and provide critical insights accurately. They are highly suitable for storing personal medical and financial information and can easily trace human beings or animals. They are implanted in the body and assist in monitoring, analyzing, and controlling the health of a patient and biological processes in the body. Besides this, they aid in identifying potential hazards, ensuring a safe environment, and improving decision-making. As a result, biochips find applications for gene, oncology, and inflammatory diagnosis and molecular analysis among individuals across the globe.

Biochips Market Trends:

At present, rising prevalence of chronic diseases, such as diabetes, blood pressure, and chronic obstructive pulmonary disease (COPD), represents one of the key factors supporting the growth of the market around the world. Besides this, the growing utilization of biochips in genomics, proteomics, and molecular diagnostics among the masses is positively influencing the market. Additionally, various benefits offered by biochips, such as reduction of time and money and the ability to provide high throughput without any requirement of heavy instruments, is contributing to the growth of the market. Apart from this, there is a rise in demand for time-saving and high-quality devices in the healthcare industry across the globe. This, coupled with the increasing preference for personalized medicines and next-generation sequencing (NGS) to treat numerous diseases among individuals, is propelling the growth of the market. In addition to this, the rising adoption of biochips for early detection of cancerous cells in the body is offering lucrative growth opportunities to industry investors. Moreover, the increasing geriatric population, along with the growing demand for biochips for drug development and discovery around the world, is offering a favorable market outlook. Furthermore, the biomedical advancement in microfluidic-based devices and innovation in lab-on-a-chip to offer quick results at initial diagnosis of infectious disease is impelling the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global biochips market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, fabrication technique, analysis method, application and end user.

Product Type Insights:

DNA Chip

Protein Chip

Lab-On-a-Chip

Enzyme Chip

The report has provided a detailed breakup and analysis of the biochips market based on the product type. This includes DNA chip, protein chip, lab-on-a-chip, and enzyme chip. According to the report, DNA chip represented the largest segment.

Fabrication Technique Insights:

Microarray

Microfluidic

A detailed breakup and analysis of the biochips market based on the fabrication technique has also been provided in the report. This includes microarray and microfluidic. According to the report, microarray accounted for the largest market share.

Analysis Method Insights:

Electrophoresis

Luminescence

Mass Spectrometry

Electrical Signals

Magnetism

A detailed breakup and analysis of the biochips market based on the analysis method has also been provided in the report. This includes electrophoresis, luminescence, mass spectrometry, electrical signals, and magnetism. According to the report, electrophoresis accounted for the largest market share.

Application Insights:

Molecular Analysis

Hybridization

Protein

Immunological

Biomolecules

Biomarker

Others

Diagnosis

Gene Diagnosis

Oncology

Inflammatory

Others

Non-Biological Usage

A detailed breakup and analysis of the biochips market based on the application has also been provided in the report. This includes molecular analysis (hybridization, protein, immunological, biomolecules, biomarker, and others), diagnosis (gene diagnosis, oncology, inflammatory, and others), and non-biological usage. According to the report, diagnosis (gene diagnosis, oncology, inflammatory, and others) accounted for the largest market share.

End User Insights:

Pharmaceutical and Biotechnology Companies

Hospitals and Diagnostics Centers

Academic and Research Institutes

Others

A detailed breakup and analysis of the biochips market based on the end user has also been provided in the report. This includes pharmaceutical and biotechnology companies, hospitals and diagnostics centers, academic and research institutes, and others. According to the report, pharmaceutical and biotechnology companies accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Spain

Russia

Italy

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Others

Latin America

Mexico

Brazil

Argentina

Others

Middle East and Africa

Turkey

Saudi Arabia

United Arab Emirates

Others

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Spain, Russia, Italy, and others); Asia Pacific (China, India, Japan, South Korea, Australia, and others); Latin America (Mexico, Brazil, Argentina, and others); and the Middle East and Africa (Turkey, Saudi Arabia, United Arab Emirates, and others). According to the report, North America (the United States and Canada) was the largest market for biochips. Some of the factors driving the North America biochips market included the growing prevalence of lifestyle diseases, rising geriatric population, presence of several biotechnology companies, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global biochips market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Agilent Technologies, Inc., bioMerieux SA, Bio-RAD Laboratories, Inc., CapitalBio Corporation, Dynamic Biosensors GmbH, EMD Millipore Corporation, Fluidigm Corporation, Illumina, Inc., Perkinelmer, Inc., Thermo Fisher Scientific, Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global biochips market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global biochips market?
  • What is the impact of each driver, restraint, and opportunity on the global biochips market?
  • What are the key regional markets?
  • Which countries represent the most attractive biochips market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the biochips market?
  • What is the breakup of the market based on the fabrication technique?
  • Which is the most attractive fabrication technique in the biochips market?
  • What is the breakup of the market based on the analysis method?
  • Which is the most attractive analysis method in the biochips market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the biochips market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the biochips market?
  • What is the competitive structure of the global biochips market?
  • Who are the key players/companies in the global biochips market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biochips Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 DNA Chip
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Protein Chip
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Lab-On-a-Chip
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Enzyme Chip
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Fabrication Technique

  • 7.1 Microarray
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Microfluidic
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Analysis Method

  • 8.1 Electrophoresis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Luminescence
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Mass Spectrometry
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Electrical Signals
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Magnetism
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Molecular Analysis
    • 9.1.1 Hybridization
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Protein
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
    • 9.1.3 Immunological
      • 9.1.3.1 Market Trends
      • 9.1.3.2 Market Forecast
    • 9.1.4 Biomolecules
      • 9.1.4.1 Market Trends
      • 9.1.4.2 Market Forecast
    • 9.1.5 Biomarker
      • 9.1.5.1 Market Trends
      • 9.1.5.2 Market Forecast
    • 9.1.6 Others
      • 9.1.6.1 Market Trends
      • 9.1.6.2 Market Forecast
  • 9.2 Diagnosis
    • 9.2.1 Gene Diagnosis
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Oncology
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 Inflammatory
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 Others
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
  • 9.3 Non-Biological Usage
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Pharmaceutical and Biotechnology Companies
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals and Diagnostics Centers
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Academic & Research Institutes
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Europe
    • 11.2.1 Germany
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 France
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 United Kingdom
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 Spain
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Russia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Italy
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Asia Pacific
    • 11.3.1 China
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 India
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 Japan
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 South Korea
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Australia
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Others
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Mexico
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Brazil
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Argentina
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
    • 11.4.4 Others
      • 11.4.4.1 Market Trends
      • 11.4.4.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Turkey
      • 11.5.1.1 Market Trends
      • 11.5.1.2 Market Forecast
    • 11.5.2 Saudi Arabia
      • 11.5.2.1 Market Trends
      • 11.5.2.2 Market Forecast
    • 11.5.3 United Arab Emirates
      • 11.5.3.1 Market Trends
      • 11.5.3.2 Market Forecast
    • 11.5.4 Others
      • 11.5.4.1 Market Trends
      • 11.5.4.2 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agilent Technologies, Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 bioMerieux SA
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bio-RAD Laboratories, Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 CapitalBio Corporation
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Dynamic Biosensors GmbH
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 EMD Millipore Corporation
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Fluidigm Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Illumina, Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Perkinelmer, Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Thermo Fisher Scientific, Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Biochips Market: Major Drivers and Challenges
  • Figure 2: Global: Biochips Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Biochips Market: Breakup by Product Type (in %), 2022
  • Figure 4: Global: Biochips Market: Breakup by Fabrication Technique (in %), 2022
  • Figure 5: Global: Biochips Market: Breakup by Analysis Method (in %), 2022
  • Figure 6: Global: Biochips Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Biochips Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Biochips Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Biochips Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 10: Global: Biochips (DNA Chip) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Biochips (DNA Chip) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Biochips (Protein Chip) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Biochips (Protein Chip) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Biochips (Lab-On-a-Chip) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Biochips (Lab-On-a-Chip) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Biochips (Enzyme Chip) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Biochips (Enzyme Chip) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Biochips (Microarray) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Biochips (Microarray) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Biochips (Microfluidic) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Biochips (Microfluidic) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Biochips (Electrophoresis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Biochips (Electrophoresis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Biochips (Luminescence) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Biochips (Luminescence) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Biochips (Mass Spectrometry) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Biochips (Mass Spectrometry) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Biochips (Electrical Signals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Biochips (Electrical Signals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Biochips (Magnetism) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Biochips (Magnetism) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Biochips (Molecular Analysis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Biochips (Molecular Analysis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Biochips (Hybridization) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Biochips (Hybridization) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Global: Biochips (Protein) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Global: Biochips (Protein) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Global: Biochips (Immunological) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Global: Biochips (Immunological) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Global: Biochips (Biomolecules) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Global: Biochips (Biomolecules) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Global: Biochips (Biomarker) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Global: Biochips (Biomarker) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Global: Biochips (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Global: Biochips (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Global: Biochips (Diagnosis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Global: Biochips (Diagnosis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Global: Biochips (Gene Diagnosis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Global: Biochips (Gene Diagnosis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Global: Biochips (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Global: Biochips (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Global: Biochips (Inflammatory) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Global: Biochips (Inflammatory) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Global: Biochips (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Global: Biochips (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Global: Biochips (Non-Biological Usage) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Global: Biochips (Non-Biological Usage) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Global: Biochips (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Global: Biochips (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Global: Biochips (Hospitals and Diagnostics Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Global: Biochips (Hospitals and Diagnostics Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Global: Biochips (Academic & Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Global: Biochips (Academic & Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Global: Biochips (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Global: Biochips (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: North America: Biochips Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: North America: Biochips Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: United States: Biochips Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: United States: Biochips Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Canada: Biochips Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Canada: Biochips Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Europe: Biochips Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Europe: Biochips Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Germany: Biochips Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Germany: Biochips Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: France: Biochips Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: France: Biochips Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: United Kingdom: Biochips Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: United Kingdom: Biochips Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Spain: Biochips Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Spain: Biochips Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Russia: Biochips Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Russia: Biochips Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Italy: Biochips Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: Italy: Biochips Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Others: Biochips Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 87: Others: Biochips Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Asia Pacific: Biochips Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 89: Asia Pacific: Biochips Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 90: China: Biochips Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 91: China: Biochips Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 92: India: Biochips Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 93: India: Biochips Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 94: Japan: Biochips Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 95: Japan: Biochips Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 96: South Korea: Biochips Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 97: South Korea: Biochips Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 98: Australia: Biochips Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 99: Australia: Biochips Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 100: Others: Biochips Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 101: Others: Biochips Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 102: Latin America: Biochips Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 103: Latin America: Biochips Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 104: Mexico: Biochips Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 105: Mexico: Biochips Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 106: Brazil: Biochips Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 107: Brazil: Biochips Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 108: Argentina: Biochips Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 109: Argentina: Biochips Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 110: Others: Biochips Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 111: Others: Biochips Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 112: Middle East and Africa: Biochips Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 113: Middle East and Africa: Biochips Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 114: Turkey: Biochips Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 115: Turkey: Biochips Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 116: Saudi Arabia: Biochips Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 117: Saudi Arabia: Biochips Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 118: United Arab Emirates: Biochips Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 119: United Arab Emirates: Biochips Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 120: Others: Biochips Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 121: Others: Biochips Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 122: Global: Biochips Industry: SWOT Analysis
  • Figure 123: Global: Biochips Industry: Value Chain Analysis
  • Figure 124: Global: Biochips Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biochips Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Biochips Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Biochips Market Forecast: Breakup by Fabrication Technique (in Million US$), 2023-2028
  • Table 4: Global: Biochips Market Forecast: Breakup by Analysis Method (in Million US$), 2023-2028
  • Table 5: Global: Biochips Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 6: Global: Biochips Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 7: Global: Biochips Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 8: Global: Biochips Market: Competitive Structure
  • Table 9: Global: Biochips Market: Key Players